Machine Learning

Aura's new Digital Wellbeing Score promises to decode teen screen habits for parents, but critics question if quantifying wellbeing is the answer.

New All-in-One unit promises faster charging, smaller footprints, and lower costs, accelerating the high-power EV charging race in North America.

Niche's 2026 rankings reveal a major shift: Americans are choosing smaller, walkable communities that blend urban access with neighborhood charm.

A new collaboration aims to solve antibody reproducibility, promising to enhance diagnostic accuracy and accelerate the future of precision oncology.

A new partnership will use predictive simulation to design ultra-durable alloys for The Exploration Company's Nyx, accelerating the future of space logistics.

Sydnexis's eye drop trial shows high efficacy in children 3-12, positioning it as a potential first-of-its-kind FDA-approved drug for myopia.

Tempest Therapeutics raises up to $6M in a critical financing deal to advance its CAR-T pipeline, balancing promising clinical data with financial pressures.

The bioconjugate CRDMO reports record profits and a $1.49B backlog, fueled by tech innovation, strategic acquisitions, and global expansion.

Ephicacy appoints biometrics SVP Jamie Powers and India Head Tyagi Swaminathan in a strategic push to dominate advanced clinical trial analytics.

At RSA Conference 2026, SOCRadar launched an AI Agent Marketplace and identity intelligence tools to combat the surge in credential-based cyberattacks.

Canadian law firms are adopting AI faster than global peers to boost profits, creating a performance gap and raising complex new ethical questions.

Tracker's new platform expansion aims to end tech fragmentation for staffing agencies by integrating payroll and compliance into a single system.

The European threat management firm is rapidly expanding in North America, leveraging a massive open-source community and a shift to proactive defense.

Genomics leader IDT launches its first IVD-grade NGS tests for cancer, aiming to standardize diagnostics and accelerate precision medicine.

With a new grant, Tessera Therapeutics is advancing its novel Gene Writing platform to engineer a scalable, single-shot cure for HIV. But can it work?

A new partnership aims to end token fraud by embedding issuer identity directly into digital assets, bridging the gap between traditional and on-chain finance.

Autonomous driving firm WeRide posts record 2025 revenue and narrows losses, fueled by aggressive international expansion and key driverless permits.

Interna Therapeutics, Oxford, and the Gates Foundation team up on a novel intranasal siRNA spray to prevent COVID, tested in a human challenge trial.

Pharma giant Sanofi inks a massive deal for Kali Therapeutics' KT501, a novel T-cell engager aiming to reset the immune system in autoimmune diseases.

With 1,600 exhibitors and a 'Smart Revolution' theme, interzum guangzhou 2026 is set to redefine the global furniture industry with AI and sustainability.